STING in tumor and host cells cooperatively work for NK cell-mediated tumor growth retardation

被引:74
|
作者
Takashima, Ken [1 ]
Takeda, Yohei [1 ]
Oshiumi, Hiroyuki [1 ,3 ]
Shime, Hiroaki [1 ]
Okabe, Masaru [2 ]
Ikawa, Masahito [2 ]
Matsumoto, Misako [1 ]
Seya, Tsukasa [1 ]
机构
[1] Hokkaido Univ, Grad Sch Med, Dept Microbiol & Immunol, Sapporo, Hokkaido 0608638, Japan
[2] Osaka Univ, Microbial Dis Res Inst, Yamadaoka 3-1, Suita, Osaka 5650871, Japan
[3] Kumamoto Univ, Grad Sch Med Sci, Dept Immunol, Kumamoto 8608556, Japan
关键词
STING; B16 cell line; NK cells; Antitumor immunity; Interferon; IMMUNOGENIC TUMORS; DI-GMP; CANCER; DNA; ACTIVATION; LIGANDS; PATHWAY; INNATE; IMMUNOTHERAPY; REJECTION;
D O I
10.1016/j.bbrc.2016.09.021
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
An interferon-inducing DNA sensor STING participates in tumor rejection in mouse models. Here we examined what mechanisms contribute to STING-dependent growth retardation of B16 melanoma sublines by NK cells in vivo. The studies were designed using WT and STING KO black mice, and B16D8 (an NK-sensitive melanoma line having STING) and STING KO B16D8 sublines established for this study. The results from tumor-implant studies suggested that STING in host immune cells and tumor cells induced distinct profiles of chemokines including CXCL10, CCL5 and IL-33, and both participated in NI( cell infiltration and activation in B16D8 tumor. Spontaneous activation of STING occurs in host-immune and tumor cells of this NK-sensitive tumor, thereby B16D8 tumor growth being suppressed in this model. Our data show that STING induces tumor cytotoxicity by NK cells through tumor and host immune cell network to contribute to innate surveillance and suppression of tumors in vivo. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:1764 / 1771
页数:8
相关论文
共 50 条
  • [1] The Host Defense Peptide Cathelicidin Is Required for NK Cell-Mediated Suppression of Tumor Growth
    Buechau, Amanda S.
    Morizane, Shin
    Trowbridge, Janet
    Schauber, Juergen
    Kotol, Paul
    Bui, Jack D.
    Gallo, Richard L.
    JOURNAL OF IMMUNOLOGY, 2010, 184 (01): : 369 - 378
  • [2] MAIT cells regulate NK cell-mediated tumor immunity
    Petley, Emma, V
    Koay, Hui-Fern
    Henderson, Melissa A.
    Sek, Kevin
    Todd, Kirsten L.
    Keam, Simon P.
    Lai, Junyun
    House, Imran G.
    Li, Jasmine
    Zethoven, Magnus
    Chen, Amanda X. Y.
    Oliver, Amanda J.
    Michie, Jessica
    Freeman, Andrew J.
    Giuffrida, Lauren
    Chan, Jack D.
    Pizzolla, Angela
    Mak, Jeffrey Y. W.
    McCulloch, Timothy R.
    Souza-Fonseca-Guimaraes, Fernando
    Kearney, Conor J.
    Millen, Rosemary
    Ramsay, Robert G.
    Huntington, Nicholas D.
    McCluskey, James
    Oliaro, Jane
    Fairlie, David P.
    Neeson, Paul J.
    Godfrey, Dale, I
    Beavis, Paul A.
    Darcy, Phillip K.
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [3] MAIT cells regulate NK cell-mediated tumor immunity
    Emma V. Petley
    Hui-Fern Koay
    Melissa A. Henderson
    Kevin Sek
    Kirsten L. Todd
    Simon P. Keam
    Junyun Lai
    Imran G. House
    Jasmine Li
    Magnus Zethoven
    Amanda X. Y. Chen
    Amanda J. Oliver
    Jessica Michie
    Andrew J. Freeman
    Lauren Giuffrida
    Jack D. Chan
    Angela Pizzolla
    Jeffrey Y. W. Mak
    Timothy R. McCulloch
    Fernando Souza-Fonseca-Guimaraes
    Conor J. Kearney
    Rosemary Millen
    Robert G. Ramsay
    Nicholas D. Huntington
    James McCluskey
    Jane Oliaro
    David P. Fairlie
    Paul J. Neeson
    Dale I. Godfrey
    Paul A. Beavis
    Phillip K. Darcy
    Nature Communications, 12
  • [4] Artemisinin sensitizes tumor cells to NK cell-mediated cytolysis
    Lu, Zhen
    Bi, Jiacheng
    Wan, Xiaochun
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 524 (02) : 418 - 423
  • [5] Augmentation of NK cell-mediated cytotoxicity to tumor cells by inhibitory NK cell receptor blockers
    Tajima, K
    Matsumoto, N
    Ohmori, K
    Wada, H
    Ito, M
    Suzuki, K
    Yamamoto, K
    INTERNATIONAL IMMUNOLOGY, 2004, 16 (03) : 385 - 393
  • [6] Sensitization of tumor cells to NK cell-mediated killing by proteasome inhibition
    Hallett, William H. D.
    Ames, Erik
    Motarjemi, Milad
    Barao, Isabel
    Shanker, Anil
    Tamang, David L.
    Sayers, Thomas J.
    Hudig, Dorothy
    Murphy, William J.
    JOURNAL OF IMMUNOLOGY, 2008, 180 (01): : 163 - 170
  • [7] Tumor escape front NK cell-mediated destruction
    Repp, A
    Mayhew, ES
    Apte, S
    Niederkorn, JY
    FASEB JOURNAL, 2000, 14 (06): : A1010 - A1010
  • [8] STING activation promotes robust immune response and NK cell-mediated tumor regression in glioblastoma models
    Berger, Gilles
    Knelson, Erik H.
    Jimenez-Macias, Jorge L.
    Nowicki, Michal O.
    Han, Saemi
    Panagioti, Eleni
    Lizotte, Patrick H.
    Adu-Berchie, Kwasi
    Stafford, Alexander
    Dimitrakakis, Nikolaos
    Zhou, Lanlan
    Chiocca, E. Antonio
    Mooney, David J.
    Barbie, David A.
    Lawler, Sean E.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2022, 119 (28)
  • [9] Functional visualization of NK cell-mediated killing of metastatic single tumor cells
    Ichise, Hiroshi
    Tsukamoto, Shoko
    Hirashima, Tsuyoshi
    Konishi, Yoshinobu
    Oki, Choji
    Tsukiji, Shinya
    Iwano, Satoshi
    Miyawaki, Atsushi
    Sumiyama, Kenta
    Terai, Kenta
    Matsuda, Michiyuki
    Rothlin, Carla, V
    ELIFE, 2022, 11
  • [10] Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection
    Kelly, JM
    Darcy, PK
    Markby, JL
    Godfrey, DI
    Takedo, K
    Yagita, H
    Smyth, MJ
    NATURE IMMUNOLOGY, 2002, 3 (01) : 83 - 90